KH801 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called KH801 for people with advanced solid tumors (cancers that have spread) that haven't been helped by other treatments. The goal is to see if it is safe and how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a solid tumor cancer (like breast, lung, or colon) that is advanced and has not responded to standard treatments.
- You have at least one tumor that can be measured on a CT scan or MRI.
- You are in fairly good health otherwise (able to do daily activities, with good kidney, liver, and blood function).
- You are not pregnant, and you agree to use birth control during and for 6 months after the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests KH617, a new treatment, in adults with advanced cancers to see if it can be given safely and whether it shows signs of benefit. It is especially focused on tumors that have few or no standard treatment options, including certain brain tumor recurrences.
This trial tests a new drug called GK01 in patients with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective, and may be an option for those who can have a tumor surgically removed.
This trial tests a new drug called KH815 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This Phase 1 trial studies how a new medicine (KC1036) works and how safe it is for people with advanced solid cancers that have grown despite standard treatments. It may help future patients by showing whether the drug can control cancer in difficult-to-treat cases.
This trial tests a new drug, Hemay181, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it can shrink tumors and how safe it is.
This trial tests a new drug called JSKN027 for people with advanced solid tumors (cancers that have spread) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink tumors.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.